June 2016
Abivax Net Loss Rises as Hepatitis B Study Hits Setback
The biotechnology company reported a first-half net loss of 8.274 million euros amid intensified research spending and a futility analysis for one of its lead candidates.
Abivax Net Loss Rises as Hepatitis B Study Fails
The biotechnology company reported a net loss of 8.274 million euros for the first half of 2016.
Dassault Systèmes Non-IFRS Net Income Per Share Rises 12.5%
The software company reported a first-half non-IFRS operating result of 410.9 million euros as it expands its 3DEXPERIENCE platform.